Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: Guidant

This article was originally published in The Gray Sheet

Executive Summary

Guidant: Files registration statement with SEC for the proposed split-off of Lilly's equity interest in Guidant. The split-off, expected to be completed during the fall, grants Lilly shareholders an opportunity "to exchange some or all of their Lilly stock for Guidant common stock," Guidant says. Terms of the deal will be "communicated by mail at the commencement of the exchange offer," the firm adds. The move would complete Lilly's divestiture of Guidant, initiated when Guidant went public last December ("The Gray Sheet" Dec. 19, 1994, p. 26)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004205

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel